Spike protein 15-16 months post-acute infection? Patterson et al.: “Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection” (substack.com)
What this means is that my ongoing use of nicotine lozenges is helpful to me (but I do need to not overuse them) after having had a bad passive exposure illness in May 2021 with some relapses at other times of the year. Once sensitized it seemed that further exposures were more likely like an allergy getting worse. I did use KN95 masks when in medical settings or busy places. Confined with poor ventilation is highest risk, along with a setting where many jabbed people might be at (medical office or business giving jabs, for example).
The S1 subunit of the jabs seems even more of a nAChR inhibitor/paralytic than the infection, having had that in early 2020.
Brief post because I am busy on a part 2 to this Substack post: Addition: #23 – B1 – thiamine.
Disclaimer: Opinions are my own and the information is provided for educational purposes within the guidelines of fair use. While I am a Registered Dietitian this information is not intended to provide individual health guidance. Please see a health professional for individual health care purposes.